| PBSA | MUC5B | MUC7 | LYS | Cys-C | Cys-S | Cys-SA | Cys-SN |
---|
Plaque forming rate | − 0.448* | − 0.590** | − 0.464* | − 0.249 | − 0.453* | − 0.453* | − 0.380 | − 0.556** |
- Plaque forming rate (%) = PFU of saliva sample/PFU of control (phosphate-buffered saline) sample × 100. Anti-IAV activity is defined as a decrease in the plaque forming rate
- Spearman’s rank correlation coefficient; *p < 0.05; **p < 0.01
- IAV influenza A virus; PFU plaque-forming units; PBSA protein-bound sialic acid; MUC5B mucin 5B; MUC7 mucin 7; LYS lysozyme C; Cys-C cystatin C; Cys-S cystatin-S; Cys-SA cystatin-SA; Cys-SN cystatin-SN